Parnaparin sodium is a low molecular weight heparin (LMWH) with antithrombotic and anticoagulant properties. It is derived from standard heparin through controlled enzymatic depolymerization, resulting in a more predictable pharmacokinetic profile and improved safety for clinical use. It is grouped under the following drug class(es): Antithrombotic agents and Carbohydrates. Its therapeutic use is listed as anticoagulants. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include Fluxum, Minidalton, Tromboparin and LowePA. Its PubChem SID is 481109368.
Parnaparin sodium
| CAS No | 9041-08-1 |
|---|---|
| Molecular Formula | N/A |
| Molecular Weight | ~5,000–6,000 Da |
| Synonyms | N/A |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Parnaparin sodium is a low molecular weight heparin (LMWH) with antithrombotic and anticoagulant properties. It is derived from standard heparin through controlled enzymatic depolymerization, resulting in a more predictable pharmacokinetic profile and improved safety for clinical use.
The listed CAS number is 9041-08-1.
The listed molecular formula is N/A.
The listed molecular weight is ~5,000–6,000 Da.
N/A.
The source lists Fluxum, Minidalton, Tromboparin and LowePA.